Editas Medicine (EDIT) Total Non-Current Liabilities (2016 - 2025)
Historic Total Non-Current Liabilities for Editas Medicine (EDIT) over the last 10 years, with Q3 2025 value amounting to $183.6 million.
- Editas Medicine's Total Non-Current Liabilities rose 2351.67% to $183.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $183.6 million, marking a year-over-year increase of 2351.67%. This contributed to the annual value of $204.2 million for FY2024, which is 3776.37% up from last year.
- Per Editas Medicine's latest filing, its Total Non-Current Liabilities stood at $183.6 million for Q3 2025, which was up 2351.67% from $186.8 million recorded in Q2 2025.
- In the past 5 years, Editas Medicine's Total Non-Current Liabilities registered a high of $204.2 million during Q4 2024, and its lowest value of $142.5 million during Q1 2024.
- In the last 4 years, Editas Medicine's Total Non-Current Liabilities had a median value of $153.6 million in 2022 and averaged $168.0 million.
- Per our database at Business Quant, Editas Medicine's Total Non-Current Liabilities tumbled by 350.49% in 2023 and then skyrocketed by 3776.37% in 2024.
- Quarter analysis of 4 years shows Editas Medicine's Total Non-Current Liabilities stood at $153.6 million in 2022, then decreased by 3.5% to $148.3 million in 2023, then soared by 37.76% to $204.2 million in 2024, then decreased by 10.1% to $183.6 million in 2025.
- Its Total Non-Current Liabilities was $183.6 million in Q3 2025, compared to $186.8 million in Q2 2025 and $194.9 million in Q1 2025.